rs2230392

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002204.4(ITGA3):​c.2155G>A​(p.Ala719Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.103 in 1,610,498 control chromosomes in the GnomAD database, including 11,729 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.095 ( 1082 hom., cov: 32)
Exomes 𝑓: 0.10 ( 10647 hom. )

Consequence

ITGA3
NM_002204.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.53

Publications

29 publications found
Variant links:
Genes affected
ITGA3 (HGNC:6139): (integrin subunit alpha 3) The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function as cell surface adhesion molecules. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 3 subunit. This subunit joins with a beta 1 subunit to form an integrin that interacts with extracellular matrix proteins including members of the laminin family. Expression of this gene may be correlated with breast cancer metastasis. [provided by RefSeq, Oct 2015]
ITGA3 Gene-Disease associations (from GenCC):
  • epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, Ambry Genetics, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030632317).
BP6
Variant 17-50078061-G-A is Benign according to our data. Variant chr17-50078061-G-A is described in ClinVar as Benign. ClinVar VariationId is 1237071.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.305 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGA3NM_002204.4 linkc.2155G>A p.Ala719Thr missense_variant Exon 17 of 26 ENST00000320031.13 NP_002195.1 P26006-2A0A140VJM0
ITGA3XM_005257308.3 linkc.1750G>A p.Ala584Thr missense_variant Exon 15 of 24 XP_005257365.1
ITGA3XM_047435922.1 linkc.2196G>A p.Ser732Ser synonymous_variant Exon 17 of 18 XP_047291878.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGA3ENST00000320031.13 linkc.2155G>A p.Ala719Thr missense_variant Exon 17 of 26 1 NM_002204.4 ENSP00000315190.8 P26006-2

Frequencies

GnomAD3 genomes
AF:
0.0952
AC:
14477
AN:
152042
Hom.:
1080
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0235
Gnomad AMI
AF:
0.0822
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.105
Gnomad EAS
AF:
0.317
Gnomad SAS
AF:
0.255
Gnomad FIN
AF:
0.0990
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.0874
Gnomad OTH
AF:
0.111
GnomAD2 exomes
AF:
0.143
AC:
35811
AN:
250822
AF XY:
0.144
show subpopulations
Gnomad AFR exome
AF:
0.0209
Gnomad AMR exome
AF:
0.236
Gnomad ASJ exome
AF:
0.0969
Gnomad EAS exome
AF:
0.324
Gnomad FIN exome
AF:
0.0999
Gnomad NFE exome
AF:
0.0911
Gnomad OTH exome
AF:
0.130
GnomAD4 exome
AF:
0.104
AC:
151264
AN:
1458338
Hom.:
10647
Cov.:
33
AF XY:
0.107
AC XY:
77698
AN XY:
724896
show subpopulations
African (AFR)
AF:
0.0183
AC:
613
AN:
33444
American (AMR)
AF:
0.230
AC:
10259
AN:
44606
Ashkenazi Jewish (ASJ)
AF:
0.0998
AC:
2602
AN:
26084
East Asian (EAS)
AF:
0.318
AC:
12597
AN:
39586
South Asian (SAS)
AF:
0.233
AC:
20011
AN:
85990
European-Finnish (FIN)
AF:
0.0981
AC:
5234
AN:
53354
Middle Eastern (MID)
AF:
0.106
AC:
610
AN:
5754
European-Non Finnish (NFE)
AF:
0.0835
AC:
92660
AN:
1109364
Other (OTH)
AF:
0.111
AC:
6678
AN:
60156
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
6213
12425
18638
24850
31063
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3618
7236
10854
14472
18090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0952
AC:
14491
AN:
152160
Hom.:
1082
Cov.:
32
AF XY:
0.103
AC XY:
7652
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.0235
AC:
975
AN:
41518
American (AMR)
AF:
0.193
AC:
2949
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
365
AN:
3472
East Asian (EAS)
AF:
0.318
AC:
1636
AN:
5144
South Asian (SAS)
AF:
0.253
AC:
1222
AN:
4822
European-Finnish (FIN)
AF:
0.0990
AC:
1049
AN:
10594
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0874
AC:
5944
AN:
68006
Other (OTH)
AF:
0.116
AC:
245
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
642
1283
1925
2566
3208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0982
Hom.:
2449
Bravo
AF:
0.0966
TwinsUK
AF:
0.0885
AC:
328
ALSPAC
AF:
0.0807
AC:
311
ESP6500AA
AF:
0.0225
AC:
99
ESP6500EA
AF:
0.0888
AC:
764
ExAC
AF:
0.138
AC:
16782
Asia WGS
AF:
0.275
AC:
955
AN:
3478
EpiCase
AF:
0.0914
EpiControl
AF:
0.0936

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
15
DANN
Uncertain
0.99
DEOGEN2
Benign
0.065
T;.
Eigen
Benign
-0.076
Eigen_PC
Benign
-0.0095
FATHMM_MKL
Benign
0.48
N
LIST_S2
Benign
0.75
T;T
MetaRNN
Benign
0.0031
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
1.4
L;L
PhyloP100
1.5
PrimateAI
Benign
0.35
T
PROVEAN
Benign
0.27
N;N
REVEL
Benign
0.010
Sift
Benign
0.36
T;T
Sift4G
Benign
0.38
T;T
Polyphen
0.20
B;B
Vest4
0.026
MPC
0.36
ClinPred
0.0099
T
GERP RS
3.2
Varity_R
0.050
gMVP
0.39
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2230392; hg19: chr17-48155425; COSMIC: COSV50307095; COSMIC: COSV50307095; API